ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Gan & Lee Pharmaceuticals clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 59 studies whose lead sponsor is Gan & Lee Pharmaceuticals. 20 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Gan & Lee Pharmaceuticals with Novo Nordisk and Eli Lilly →

Pipeline: 14 programs

Each counted once: 14 with a study Gan & Lee Pharmaceuticals leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 4 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Gan & Lee Pharmaceuticals’ own registered studies; Gan & Lee Pharmaceuticals’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Gan & Lee Pharmaceuticals’ studies test, most open studies first — 7 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

7 of Gan & Lee Pharmaceuticals’ studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. 2F
  5. M
  6. A
  7. M
  8. 1J
  9. 1J
  10. 1A
  11. S
  12. O
  13. 1N

Add all 7 to your calendar (.ics) → With an account.

All 59 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2034%Recruiting 11 · Not yet recruiting 9
  • Under way, not recruiting712%
  • Completed3153%
  • Stopped early12%

Phase

Where

  • China46
  • Germany7
  • United States7
  • Hungary2
  • Poland2
  • Czechia2

Over the years

  1. 15
  2. 16
  3. 17
  4. 18
  5. 19
  6. 20
  7. 21
  8. 22
  9. 23
  10. 24
  11. 1725
  12. 1426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Gan & Lee Pharmaceuticals.

  • Gan & Lee Pharmaceuticals.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies
  • Gan and Lee Pharmaceuticals, USA
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    29 studies

Focus areas

Conditions Gan & Lee Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 59. Browse all 59 →